Why is Tatva Chintan falling/rising?

As of 25-Jul, Tatva Chintan Pharma Chem Ltd's stock price is rising, currently at Rs. 1,146.95, reflecting an increase of Rs. 126.95 or 12.45%. The stock has recently hit a new 52-week high of Rs. 1,219.9 and has outperformed its sector by 13.75%. Over the past two days, it has gained 14.81%, and it opened with a gain of 2.95% today. The stock has shown strong performance over various periods, with a 1-month return of 21.86% and a year-to-date return of 29.92%, while it has consistently traded above its moving averages. However, there has been a notable decline in investor participation, with delivery volume falling by 72.25% against the 5-day average, which may indicate some caution among investors despite the positive price movement. In the broader market context, while the stock has been rising, the benchmark index, Sensex, has experienced a slight decline of 0.36% over the past week. This contrast highlights the stock's strong performance relative to the market, as it has managed to generate positive returns even when the broader market has struggled, evidenced by its 15.65% return over the past year compared to the negative returns of the BSE500. The company's low debt-to-equity ratio and the fact that majority shareholders are promoters further support investor confidence, contributing to the stock's upward momentum despite the recent drop in trading volume.